130 related articles for article (PubMed ID: 30387237)
1. Indwelling ports for prophylactic RBC exchanges in sickle cell patients: Comparison of bard and vortex ports.
Lawicki S; Craig-Owens L; Bream PR; Eichbaum Q
J Clin Apher; 2018 Dec; 33(6):666-670. PubMed ID: 30387237
[TBL] [Abstract][Full Text] [Related]
2. Use of a dual lumen port for automated red cell exchange in adults with sickle cell disease.
Shrestha A; Jawa Z; Koch KL; Rankin AB; Xiang Q; Padmanabhan A; Karafin MS; Field JJ
J Clin Apher; 2015 Dec; 30(6):353-8. PubMed ID: 25790325
[TBL] [Abstract][Full Text] [Related]
3. Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion.
Ziemba Y; Xu C; Fomani KM; Nandi V; Yuan T; Rehmani S; Sachais BS; Appiah-Kubi AO; Aygun B; Louie JE; Shi PA
Transfusion; 2021 Feb; 61(2):526-536. PubMed ID: 33368343
[TBL] [Abstract][Full Text] [Related]
4. Cathlink 20: a subcutaneous implanted central venous access device used in children with sickle cell disease on long-term erythrocytapheresis--a report of low complication rates.
Raj A; Bertolone S; Bond S; Burnett D; Denker A
Pediatr Blood Cancer; 2005 Jun; 44(7):669-72. PubMed ID: 15700248
[TBL] [Abstract][Full Text] [Related]
5. Use of dual lumen ports for red blood cell exchange: A comparison of adults and children with sickle cell disease.
Su L; Nizzi F; Jamshidi R; Gomez E; Perumbeti A; Mirea L; Shah S
J Clin Apher; 2020 Aug; 35(4):351-357. PubMed ID: 32629525
[TBL] [Abstract][Full Text] [Related]
6. Effects of repleting organic phosphates in banked erythrocytes on plasma metabolites and vasoactive mediators after red cell exchange transfusion in sickle cell disease.
Lopez Domowicz DA; Welsby I; Esther CR; Zhu H; Marek RD; Lee G; Shah N; Poisson JL; McMahon TJ
Blood Transfus; 2020 May; 18(3):200-207. PubMed ID: 32203007
[TBL] [Abstract][Full Text] [Related]
7. Use of infusion ports in patients with sickle cell disease: Indications and complications.
Ilonze C; Anderson M; Stubblefield A; Journeycake J; Sinha AA
Pediatr Blood Cancer; 2022 Feb; 69(2):e29445. PubMed ID: 34786823
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients.
Fasano RM; Leong T; Kaushal M; Sagiv E; Luban NL; Meier ER
Transfusion; 2016 Jul; 56(7):1707-15. PubMed ID: 26997031
[TBL] [Abstract][Full Text] [Related]
9. Revisiting the benefits of isovolemic hemodilution red cell exchange for sickle cell disease.
Reddy MS; Alkashash A; Nord A; Tetrick A
J Clin Apher; 2023 Oct; 38(5):522-528. PubMed ID: 37092306
[TBL] [Abstract][Full Text] [Related]
10. Performance characteristics of the PowerFlow apheresis port: Early experience.
Garrity D; Graves M; Linden J; St Pierre P; Ducharme P; Zhao Y; Greene M; Vauthrin M; Weinstein R
J Clin Apher; 2019 Dec; 34(6):661-665. PubMed ID: 31424114
[TBL] [Abstract][Full Text] [Related]
11. Complications of PORT-A-CATH® in patients with sickle cell disease.
Alkindi S; Matwani S; Al-Maawali A; Al-Maskari B; Pathare A
J Infect Public Health; 2012 Mar; 5(1):57-62. PubMed ID: 22341844
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Inversion ("flipping") Rates Among Different Port Designs: A Single-Center Experience.
Etezadi V; Trerotola SO
Cardiovasc Intervent Radiol; 2017 Apr; 40(4):553-559. PubMed ID: 28004169
[TBL] [Abstract][Full Text] [Related]
13. Metabolic impact of red blood cell exchange with rejuvenated red blood cells in sickle cell patients.
Gehrke S; Shah N; Gamboni F; Kamyszek R; Srinivasan AJ; Gray A; Landrigan M; Welsby I; D'Alessandro A
Transfusion; 2019 Oct; 59(10):3102-3112. PubMed ID: 31385330
[TBL] [Abstract][Full Text] [Related]
14. Comparison of automated red cell exchange transfusion and simple transfusion for the treatment of children with sickle cell disease acute chest syndrome.
Saylors RL; Watkins B; Saccente S; Tang X
Pediatr Blood Cancer; 2013 Dec; 60(12):1952-6. PubMed ID: 24000077
[TBL] [Abstract][Full Text] [Related]
15. Catheter associated thromboses in patients with sickle cell anaemia and dual lumen Vortex apheresis ports are common and can be clinically asymptomatic.
Brewin JN; Crowley MP; Kesse-Adu R; Stuart-Smith S; Awogbade M; Howard J
Br J Haematol; 2020 Jun; 189(5):e198-e200. PubMed ID: 32207154
[No Abstract] [Full Text] [Related]
16. Peripheral Blood Smear Detection of Asymptomatic Central Line Infection in a Patient With Sickle Cell Disease.
Carll TC; Mariani R; Schafernak K; Snowberger T; Jacobsen J; Gomez E; Su L
J Pediatr Hematol Oncol; 2022 Apr; 44(3):98-99. PubMed ID: 35180760
[TBL] [Abstract][Full Text] [Related]
17. Power-injectable ports: safety during placement, therapeutic use, and contrast administration during computed tomography procedures.
Alexander MD; Morrison HL
J Vasc Access; 2012; 13(4):432-7. PubMed ID: 22610789
[TBL] [Abstract][Full Text] [Related]
18. Prospective investigation of a subcutaneous, implantable central venous access device for therapeutic plasma exchange in adults with neurological disorders.
Pertiné B; Razvi SA; Weinstein R
J Clin Apher; 2002; 17(1):1-6. PubMed ID: 11948699
[TBL] [Abstract][Full Text] [Related]
19. Red cell exchange for patients with sickle cell disease: an international survey of current practices.
Karafin MS; Hendrickson JE; Kim HC; Kuliya-Gwarzo A; Pagano MB; Perumbeti A; Shi PA; Tanhehco YC; Webb J; Wong E; Eichbaum Q
Transfusion; 2020 Jul; 60(7):1424-1433. PubMed ID: 32583456
[TBL] [Abstract][Full Text] [Related]
20. Functional evaluation of conventional 'Celsite' venous ports versus 'Vortex' ports with a tangential outlet: a prospective randomised pilot study.
Goossens GA; Verbeeck G; Moons P; Sermeus W; De Wever I; Stas M
Support Care Cancer; 2008 Dec; 16(12):1367-74. PubMed ID: 18414904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
